SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
2 hedge funds and large institutions have $2.18M invested in SpringWorks Therapeutics in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
1% more capital invested
Capital invested by funds: $2.16M → $2.18M (+$19.1K)
0.05% less ownership
Funds ownership: 0.05% → 0% (-0.05%)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.9K |
SWTX Hedge Fund Activity: Q4 2025 in Review
2 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2025, worth a combined $2.18M — up 0.88% from $2.16M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SWTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Osaic Holdings, exiting entirely with an estimated $3.9K sold.
- 2 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2025, down from 3 in Q3 2025.
- Funds reported $2.18M of SpringWorks Therapeutics stock for Q4 2025, up 0.88% quarter-over-quarter.
- 0 funds opened new SpringWorks Therapeutics positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest SpringWorks Therapeutics seller in Q4 2025 was Osaic Holdings, an estimated $3.9K sold.
Based on aggregated 13F filings for Q4 2025.